These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4092268)

  • 21. 4-Substituted 4-(1H-1,2,3-triazol-1-yl)piperidine: novel C7 moieties of fluoroquinolones as antibacterial agents.
    Huang X; Zhang A; Chen D; Jia Z; Li X
    Bioorg Med Chem Lett; 2010 May; 20(9):2859-63. PubMed ID: 20347299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study on metabolism of pyridonecarboxylic acid. I. Isolation and identification of metabolites of (+-)-7-(3-amino-1-pyrrolidinyl)-6-fluoro-1- (2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid p-toluenesulfonate hydrate (T-3262) in urine].
    Tai M; Konishi Y; Sugimoto Y; Demachi K; Maeda T
    Jpn J Antibiot; 1989 Apr; 42(4):868-75. PubMed ID: 2769939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyridonecarboxylic acids as antibacterial agents. VIII. An alternative synthesis of enoxacin via fluoronicotinic acid derivatives.
    Miyamoto T; Egawa H; Matsumoto J
    Chem Pharm Bull (Tokyo); 1987 Jun; 35(6):2280-5. PubMed ID: 3478152
    [No Abstract]   [Full Text] [Related]  

  • 24. Quinolone antibacterial agents. Synthesis and structure-activity relationships of a series of amino acid prodrugs of racemic and chiral 7-(3-amino-1-pyrrolidinyl)quinolones. Highly soluble quinolone prodrugs with in vivo pseudomonas activity.
    Sanchez JP; Domagala JM; Heifetz CL; Priebe SR; Sesnie JA; Trehan AK
    J Med Chem; 1992 May; 35(10):1764-73. PubMed ID: 1366133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic antibacterials. VI. 7-[1-Substituted 2-(5-nitro-2-furyl) vinyl]-1,8-naphthyridines.
    Nishigaki S; Mizushima N; Senga K
    Chem Pharm Bull (Tokyo); 1976 Jul; 24(7):1658-61. PubMed ID: 975427
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on the antibacterial activity of 1-substituted 1,4-dihydro-7-(2-(5-nitro-2-furyl)vinyl)-4-oxo-1,8-naphthyridine derivatives.
    Nagasaki S; Nakazawa N; Osada Y; Hashizume T; Oshima Y
    Chem Pharm Bull (Tokyo); 1972 Apr; 20(4):639-49. PubMed ID: 5045609
    [No Abstract]   [Full Text] [Related]  

  • 27. Pyridonecarboxylic acids as antibacterial agents. IX. Synthesis and structure-activity relationship of 3-substituted 10-(1-aminocyclopropyl)-9-fluoro-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]- 1,4-benzoxazine-6-carboxylic acids and their 1-thio and 1-aza analogues.
    Todo Y; Takagi H; Iino F; Fukuoka Y; Takahata M; Okamoto S; Saikawa I; Narita H
    Chem Pharm Bull (Tokyo); 1994 Dec; 42(12):2569-74. PubMed ID: 7697774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on biologically active haloganenated compounds. III. Synthesis and antibacterial activity of 7-fluoromethyl-1,8-naphthyridine and quinoline derivatives.
    Tani J; Mushika Y; Yamaguchi T
    Chem Pharm Bull (Tokyo); 1982 Oct; 30(10):3517-29. PubMed ID: 7160009
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis and antibacterial activities of substituted 7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxyl ic acids.
    Hayakawa I; Hiramitsu T; Tanaka Y
    Chem Pharm Bull (Tokyo); 1984 Dec; 32(12):4907-13. PubMed ID: 6534539
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies on pyridonecarboxylic acids as antibacterial agents. VIII. Synthesis and structure-activity relationships of 1-(P-fluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl) cinnoline-3-carboxylic acid and analogues].
    Mu YQ; Guo HY; Zhang ZP
    Yao Xue Xue Bao; 1989; 24(4):255-9. PubMed ID: 2816385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antivertigo agents. III. Synthesis of 5,6,7,8-tetrahydro-1,6-naphthyridine methyl homologs.
    Shiozawa A; Ichikawa Y; Komuro C; Kurashige S; Miyazaki H; Yamanaka H; Sakamoto T
    Chem Pharm Bull (Tokyo); 1984 Jul; 32(7):2522-9. PubMed ID: 6499080
    [No Abstract]   [Full Text] [Related]  

  • 32. Synthetic antibacterials. VII. N-(1,8-naphthyridin-7-yl)-methylenamine derivatives.
    Nishigaki S; Mizushima N; Senga K
    Chem Pharm Bull (Tokyo); 1977 Feb; 25(2):349-52. PubMed ID: 852097
    [No Abstract]   [Full Text] [Related]  

  • 33. [Synthesis and preliminary pharmacological screening of 2,4-disubstituted N,N-dialkyl-1,8-naphthyridine-3-carboxamides].
    Di Braccio M; Roma G; Balbi A; Sottofattori E; Carazzone M
    Farmaco; 1989 Sep; 44(9):865-81. PubMed ID: 2604838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and antibacterial activity of naphthyridone derivatives containing mono/difluoro-methyloxime pyrrolidine scaffolds.
    Lv K; Liu ML; Feng LS; Sun LY; Sun YX; Wei ZQ; Guo HQ
    Eur J Med Chem; 2012 Jan; 47(1):619-25. PubMed ID: 22079379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SYNTHESIS AND IN VITRO ANTIPROLIFERATIVE SCREENING OF NEW 2,7-NAPHTHYRIDINE-3-CARBOXYLIC ACID HYDRAZIDE DERIVATIVES.
    Wójcicka A; Becan L
    Acta Pol Pharm; 2015; 72(2):297-305. PubMed ID: 26642680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on pyridonecarboxylic acids as antibacterial agents. V. Synthesis and antibacterial activity of pivaloyloxymethyl 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-methyl-1-piperazinyl) quinoline-3-carboxylate and its analogues].
    Guo HY; Tang Y; Li ZR; Yan GH; Zhang ZP
    Yao Xue Xue Bao; 1987 May; 22(5):373-6. PubMed ID: 3687464
    [No Abstract]   [Full Text] [Related]  

  • 37. Synthesis and in vitro antibacterial activity of gemifloxacin derivatives containing a substituted benzyloxime moiety.
    Feng L; Lv K; Liu M; Wang S; Zhao J; You X; Li S; Cao J; Guo H
    Eur J Med Chem; 2012 Sep; 55():125-36. PubMed ID: 22841282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of 1,8-naphthyridine derivatives. Potential antihypertensive agents. II.
    Da Settimo A; Ferrarini PL; Mori C; Primofiore G; Subissi A
    Farmaco Sci; 1986 Nov; 41(11):827-38. PubMed ID: 2879740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antivertigo agents. V. Quantitative structure-activity relationships of 6-[2-(4-aryl-1-piperazinyl)ethyl]-5,6,7,8-tetrahydro-1,6-naphthyridine s.
    Shiozawa A; Kogo Y; Ichikawa Y; Komuro C; Ishikawa M; Kurashige S; Miyazaki H; Yamanaka H; Sakamoto T
    Chem Pharm Bull (Tokyo); 1985 Dec; 33(12):5332-40. PubMed ID: 3833382
    [No Abstract]   [Full Text] [Related]  

  • 40. Antimycobacterial activities of novel 1-(cyclopropyl/tert-butyl/4-fluorophenyl)-1,4-dihydro- 6-nitro-4-oxo-7-(substituted secondary amino)-1,8-naphthyridine-3-carboxylic acid.
    Sriram D; Senthilkumar P; Dinakaran M; Yogeeswari P; China A; Nagaraja V
    J Med Chem; 2007 Nov; 50(24):6232-9. PubMed ID: 17960928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.